Skip to main content

Advertisement

SpringerLink
Log in

In vitro effect of cefodizime, imipenem/cilastatin and co-trimoxazole on dexamethasone and cyclosporin A depressed phagocytosis

  • Experimental Studies
  • Originalia
  • Published:
Infection Aims and scope Submit manuscript

Summary

Phagocytosis is an important part of the host defense against infection. Antibiotics can influence phagocytic function. In the present study, leukocyte metabolic response to phagocytic challenge by latex was assessed in relation toin vitro addition of cotrimoxazole, imipenem/cilastatin, cefodizime, dexamethasone (DXM), and/or cyclosporin A (CsA). Using latex particles as phagocytic challenge, glucose-1-14C utilization and14CO2 production were measured by liquid scintillation counting. The phagocytic response was impaired byin vitro addition of DXM or CsA and this setup was used as an experimental model of immunodepression. The addition of co-trimoxazole to control samples (without DXM or CsA) depressed the response to latex challenge, whereas imipenem and cefodizime had a neutral effect. In the presence of DXM, co-trimoxazole induced a further decrease. The depressive effect of DXM was partially neutralized in the presence of cefodizime. With CsA depression, co-trimoxazole also induced a further decrease, imipenem had a neutral effect, while cefodizime partially restored the CsA suppressed reaction. Co-trimoxazole depressed the phagocytic response, imipenem had a neutral effect, whereas cefodizime restored the experimentally induced immunosuppression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hauser, W., Remington, J.: Effect of antibiotics on immune response. Am. J. Med. 72 (1982) 711–716.

    Article  PubMed  CAS  Google Scholar 

  2. Van Vlem, B., Vanholder, R., De Paepe, P., Vogelaers, D., Ringoir, S.: Immunomodulating effects of antibiotics: literature review. Infection 24 (1996) 275–291.

    Article  PubMed  Google Scholar 

  3. Gemmell, C.: Antibiotics and neutrophil function-potential immunomodulating activities. J. Antimicrob. Chemother. 31 (Suppl. B) (1993) 23–33.

    PubMed  CAS  Google Scholar 

  4. Funk, J., Ernst, M., Schönharting, M., Zabel, P.: Pentoxifylline exerts synergistic immunomodulatory effects in combination with dexamethasone or cyclosporin. A. Int. J. Immunopharmacol. 17 (1995) 1007–1016.

    Article  PubMed  CAS  Google Scholar 

  5. Baud, L., Perez, J., Ardaillou, R.: Dexamethasone and hydrogen peroxide production by mesangial cells during phagocytosis. Am. J. Physiol. 250 (1986) F596-F604.

    PubMed  CAS  Google Scholar 

  6. Ringoir, S., Van Landschoot, N., De Smet, R.: Inhibition of phagocytosis by a middle molecular fraction from ultrafiltrate. Clin. Nephrol. 13 (1980) 109–112.

    PubMed  CAS  Google Scholar 

  7. Vanholder, R., Ringoir, S., Dhondt, A., Hakim, R.: Phagocytosis in uremic and hemodialysis patients: a prospective and cross sectional study. Kidney Int. 39 (1991) 320–327.

    Article  PubMed  CAS  Google Scholar 

  8. Baehner, R., Nathan, D., Karnovsky, M.: Correction of metabolic deficiencies in the leukocytes of patients with chronic granulomatous disease. J. Clin. Invest. 49 (1970) 865–870.

    PubMed  CAS  Google Scholar 

  9. Donabedian, H.: Congenital and acquired neutrophil abnormalities. In:Klempner, M., Styrt, B., Ho, J. (eds.): Phagocytes and disease. Kluwer Academic Publishers, Dordrecht 1989, pp. 103–118.

    Google Scholar 

  10. Sanford, J., Gilbert, D., Sande, M.: The Sanford guide to antimicrobial therapy. 10th ed. of the Belgian version 1996, pp. 66–67.

  11. Brockmeier, D., Dagrosa, E.: Pharmacokinetic profile of cefodizime. Infection 20 (Suppl. 1) (1992) S14-S17.

    Article  PubMed  CAS  Google Scholar 

  12. Hennequin, C., Page, B., Roux, P., Legendre, C., Kreis, H.: Outbreak ofPneumocystis carinii pneumonia in a renal transplant unit. Eur. J. Clin. Microbiol. Infect. Dis. 14 (1995) 122–126.

    Article  PubMed  CAS  Google Scholar 

  13. Hoyle, C., Goldman, J.: Life-threatening infections occurring more than 3 months after BMT. 18 UK Bone Marrow Transplant Teams. Bone Marrow Transplant 14 (1994) 247–252.

    PubMed  CAS  Google Scholar 

  14. Kauffman, C., Liepman, M., Bergman, A., Miodusewski, J.: Trimethoprim-sulfamethoxazole prophylaxis in neutropenic patients. Am. J. Med. 74 (1983) 599–607.

    Article  PubMed  CAS  Google Scholar 

  15. Fox, B., Sollinger, H., Belzer, F., Maki, D.: A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulphamethoxazole, effects on the microflora, and the cost benefit of prophylaxis. Am. J. Med. 89 (1990) 255–274.

    Article  PubMed  CAS  Google Scholar 

  16. Ghilchick, M., Morris, A., Reeves, D.: Immunosuppressive powers of the antibacterial agent trimethoprim. Nature 227 (1970) 393–394.

    Article  Google Scholar 

  17. Arvilommi, H., Vuori, M., Salmi, A.: Immunosuppression by cotrimoxazole. Br. Med. J. 3 (1972) 761–762.

    PubMed  CAS  Google Scholar 

  18. Duncker, D., Ullmann, U.: Influence of various antimicrobial agents on the chemiluminescence of phagocytosing human granulocytes. Chemotherapy 32 (1986) 18–24.

    PubMed  CAS  Google Scholar 

  19. Siegel, J., Remington, J.: Effect of antimicrobial agents on chemiluminescence of human polymorphonuclear leukocytes in response to phagocytosis. J. Antimicrob. Chemother. 10 (1982) 505–515.

    Article  PubMed  CAS  Google Scholar 

  20. Welch, W., Davis, D., Thrupp, L.: Effect of antimicrobial agents on human polymorphonuclear leukocyte microbicidal function. Antimicrob. Agents Chemother. 20 (1981) 15–20.

    CAS  Google Scholar 

  21. Anderson, R., Grabow, G., Oosthuizen, R., Theron, A., Van Rensburg, A.: Effects of sulfamethoxazole and trimethoprim on human neutrophil and lymphocyte functionsin vitro: in vivo effects of co-trimoxazole. Antimicrob. Agents Chemother. 17 (1980) 322–326.

    PubMed  CAS  Google Scholar 

  22. Melby, K., Midtvedt, T.: Effects of antibacterial agents on the elimination of32P-labelledEscherichia coli by human polymorphonuclear cells (PMN). Acta Path. Microbiol. Scand. Sect. B. 89 (1981) 129–131.

    CAS  Google Scholar 

  23. Emmanouilides, C., Lianou, P., Bassaris, H., Papavassiliou, J.: Trimethoprim, sulphamethoxazole, bacterial adhesion and polymorphonuclear leucocyte function. J. Antimicrob. Chemother. 26 (1990) 803–812.

    Article  PubMed  CAS  Google Scholar 

  24. Von Hahn, H., Kuhring, D., Trautmann, M., Diamantstein, T.: Einfluß von Cefaclor, Doxycyclin und weiteren oralen Antibiotika auf die Phagozytose polymorphkerniger Granulozyten und PHA-induzierte Stimulation von Blutlymphozyten des Menschen. Arzneim. Forsch./Drug Res. 35 (1985) 543–546.

    CAS  Google Scholar 

  25. Mini, E., Novelli, A., Coronnello, M., Fallani, S., Pesciullesi, A., Periti, P.:In vitro effects of brodimoprim on human polymorphonuclear leukocyte functions. Preliminary results. J. Chemother. 5 (1993) 499–501.

    PubMed  CAS  Google Scholar 

  26. Neu, H., Labthavikul, P.: Comparativein vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its β-lactamase stability. Antimicrob. Agents Chemother. 21 (1982) 180–187.

    PubMed  CAS  Google Scholar 

  27. Eron, L., Hixon, D., Park, C., Goldenberg, R., Poretz, D.: Imipenem versus moxalactam in the treatment of serious infections. Antimicrob. Agents Chemother. 24 (1983) 841–846.

    PubMed  CAS  Google Scholar 

  28. Rodriguez, A., Pariente, J., Prieto, J., Barriga, C.: Effects of cefmetazole, cefoxitin, and imipenem on polymorphonuclear leukocytes. Gen. Pharmac. 18 (1987) 613–615.

    CAS  Google Scholar 

  29. Rodriguez, A., Barriga, C., De La Fuente, M.: Phagocytic function and antibody-dependent cellular cytotoxicity of human neutrophils in the presence of N-formimidoyl thienamycin. Agents Actions 31 (1990) 86–95.

    Article  PubMed  CAS  Google Scholar 

  30. Rodriguez, A., Barriga, C., De La Fuente, M.: Mechanisms of action involved in the chemoattractant activity of three beta-lactamic antibiotics upon human neutrophils. Biochem. Pharmacol. 41 (1991) 931–936.

    Article  PubMed  CAS  Google Scholar 

  31. Pasqui, A., Di Renzo, M., Bruni, F., Fanetti, G., Campoccia, G., Auteri, A.: Impenem and immune response:in vitro andin vivo studies. Drugs Exp. Clin. Res. 21 (1995) 17–22.

    PubMed  CAS  Google Scholar 

  32. Nunez, R., Rodriguez, A., Barriga, C., De La Fuente, M.:In vitro andin vitro effects of imipenem on phagocytic activity of murine peritoneal macrophages. APMIS 97 (1989) 879–886.

    Article  PubMed  CAS  Google Scholar 

  33. Cuffini, A., Tullio, V., Allocco, A., Fazari, S., Giachino, F., Carlone, N.: EnhancedStaphylococcus aureus susceptibility to immunodefences induced by sub-inhibitory and bactericidal concentrations of imipenem. J. Antimicrob. Chemother. 31 (1993) 559–568.

    Article  PubMed  CAS  Google Scholar 

  34. Prins, J., Kuijper, E., Mevissen, M., Speelman, P., Van Deventer, S.: Release of tumor necrosis factor alpha and interleukin 6 during antibiotic killing ofEscherichia coli in whole blood: influence of antibiotic class, antibiotic concentration, and presence of septic serum. Infect. Immun. 63 (1995) 2236–2242.

    PubMed  CAS  Google Scholar 

  35. Bucklin, S., Fujihara, Y., Leeson, M., Morrison, D.: Differential antibiotic-induced release of endotoxin from gram-negative bacteria. Eur. J. Clin. Microbiol. Infect. Dis. 13 (Suppl. 1) (1994) S43-S51.

    Article  PubMed  Google Scholar 

  36. Grochla, I., Ko, H., Beuth, J., Roszkowski, K., Roszkowski, W., Pulverer, G.: Effects of beta-lactam antibiotics imipenem/cilastatin and cefodizime on cellular and humoral immune responses in BALB/c-mice. Zbl. Bakt. 274 (1990) 250–258.

    CAS  Google Scholar 

  37. Soussy, C., Chanal, M., Kitzis, M.: Thein vitro activity of cefodizime: a review. J. Antimicrob. Chemother. 26 (Suppl. C) (1990) 13–21.

    PubMed  CAS  Google Scholar 

  38. Knothe, H., Shah, P.:In vitro activity of cefodizime. Infection 20 (Suppl. 1) (1992) S3-S8.

    Article  PubMed  CAS  Google Scholar 

  39. Labro, M., el Benna, J.: Comparison of cefodizime with various cephalosporins for their indirect effect on the human neutrophil oxidative burstin vitro. J. Antimicrob. Chemother. 26 (Suppl. C) (1990) 49–57.

    CAS  Google Scholar 

  40. Labro, M., Amit, N., Babin-Chevaye, C., Hakim, J.: Cefodizime potentiation of human neutrophil oxygen-independent bactericidal activity. J. Antimicrob. Chemother. 19 (1987) 331–341.

    Article  PubMed  CAS  Google Scholar 

  41. Fietta, A., Bersani, C., Bertoletti, R., Grassi, F., Gialdroni Grassi, G.:In vitro andex vivo enhancement of nonspecific phagocytosis by cefodizime. Chemotherapy 34 (1988) 430–436.

    Article  PubMed  CAS  Google Scholar 

  42. Limbert, M., Bartlett, R., Dickneite, G., Klesel, N., Schorlemmer, H., Seibert, G., Winkler, I., Schrinner, E.: Cefodizime, an aminothiazolyl cephalosporin. IV. Influence on the immune system. J. Antibiot. 37 (1984) 1719–1726.

    PubMed  CAS  Google Scholar 

  43. Shin, W., Min, C., Kim, Y., Yoo, J., Kang, M.:In vitro effects on cefodizime on leucocyte functions and colony formation from granulocyte-monocyte progenitors. J. Antimicrob. Chemother. 37 (1996) 93–103.

    Article  PubMed  CAS  Google Scholar 

  44. Limbert, M., Müllner, H., Shah, P.: Influence of cefodizime on the reagibility of human leukocytes. Infection 20 (Suppl. 1) (1992) S48-S50.

    Article  PubMed  CAS  Google Scholar 

  45. Shaio, M., Chang, F.: Influence of cefodizime on chemotaxis and the respiratory burst in neutrophils from diabetics. J. Antimicrob. Chemother. 26 (1990) 55–59.

    Article  PubMed  CAS  Google Scholar 

  46. Pulverer, G.: Effects of cefodizime and cefotaxime on cellular and humoral immune responses. Infection 20 (Suppl. 1) (1992) S41-S44.

    Article  PubMed  CAS  Google Scholar 

  47. Meroni, P., Capsoni, F., Borghi, M. Barcellini, W., Minonzio, F., Ongari, A., Fain, C., Hu, C., Brambilla, G., Pettenati, C., Zanussi, C.: Immunopharmacological activity of cefodizime in young and elderly subjects:in vitro andex vivo studies. Infection 20 (Suppl. 1) (1992) S61-S63.

    Article  PubMed  CAS  Google Scholar 

  48. Miyake, Y., Tomonaga, M., Tokoh, T., Yamada, Y., Ishida, N.: Therapeutic efficacy of cefodizime against experimental infections in immunosuppressed mice. Chemotherapy 36 (1988) 128–139.

    CAS  Google Scholar 

  49. Anteri, A., Pasqui, A., Bruni, F., Saletti, M., Mazza, S., Di Renzo, M., Maggiore, D., Di Perri, T.: Effect of cefodizime on immunological defects induced by surgical stress. Drugs. Exp. Clin. Res. 17 (1991) 555–561.

    Google Scholar 

  50. Dammacco, F., Benvestito, S.: Effects of cefodizime on non-specific immune functions in patients with multiple myeloma. Infection 20 (Suppl. 1) (1992) S64-S66.

    Article  PubMed  Google Scholar 

  51. Vanholder, R., Van Landschoot, N., Dagrosa, E., Ringoir, S.: Cefodizime: a new cephalosporin with apparent immune-stimulating properties in chronic renal failure. Nephrol. Dial. Transplant. 3 (1988) 221–224.

    PubMed  CAS  Google Scholar 

  52. Wenisch, C., Parschalk, B., Hasenhündl, M., Wiesinger, E., Graninger, W.: Effect of cefodizime and ceftriazone on phagocytic function in patients with severe infections. Antimicrob. Agents Chemother. 39 (1995) 672–676.

    PubMed  CAS  Google Scholar 

  53. Oishi, K., Matsumoto, K., Yamamoto, M., Morito, T., Yoshida, T.: Stimulatory effect of cefodizime on macrophage-mediated phagocytosis. J. Antibiot. Tokyo 42 (1989) 989–992.

    PubMed  CAS  Google Scholar 

  54. Labro, M.: Cetodizime as a biological response modifier: a review of itsin vivo, ex vivo, andin vitro immunomodulatory properties. J. Antimicrob. Chemother. 26 (Suppl. C) (1990) 37–47.

    PubMed  CAS  Google Scholar 

  55. Stevens, D., Bryant, A., Huffman, J., Thompson, K., Allen, R.: Analysis of circulating phagocyte activity measured by whole blood luminescence: correlations with clinical status. J. Infect. Dis. 170 (1994) 1463–1472.

    PubMed  CAS  Google Scholar 

  56. Strom, T.: Graft rejection and immunosuppression in kidney transplantation. In:Cameron, S., Davison, A., Grünfeld, J. P., Kerr, D., Ritz, E. (eds.). Oxford textbook of clinical nephrology, Oxford University Press, Oxford 1992, pp. 1551–1559.

    Google Scholar 

  57. Mandell, L.: Effects of antimicrobials and antineoplastic drugs on the phagocytic and microbicidal function of the polymorphonuclear leukocytes. Rev. Infect. Dis. 4 (1982) 683–697.

    PubMed  CAS  Google Scholar 

  58. Kuby, J.: Immunology. W. H. Freeman and Company, New York 1992, pp. 496–497.

    Google Scholar 

  59. Ponticelli, C., Passerini, P.: Conventional treatment of idiopathic nephrotic syndrome and membranous nephropathy in adults. Clin. Nephrol. 35 (Suppl. 1) (1991) 16–21.

    Google Scholar 

  60. Mueller, W., Herrmann, B.: Cyclosporin A for psoriasis. N. Engl. J. Med. 301 (1979) 555.

    PubMed  CAS  Google Scholar 

  61. Van Rijthoven, A., Dijkmans, B., Goei The H., Hermans, J., Montnor-Beckers, Z., Jacobs, P., Cats, A.: Cyclosporin treatment for rheumatoid arthritis. A placebo controlled, double blind, multicenter study. Ann. Rheum. Dis. 45 (1986) 726–731.

    Article  PubMed  Google Scholar 

  62. Kahan, B.: Cyclosporine. N. Engl. J. Med. 321 (1989) 1725–1738.

    Article  PubMed  CAS  Google Scholar 

  63. Andrus, L., Lafferty, K.: Inhibition of T-cell activity by cyclosporin A. Scand. J. Immunol. 15 (1982) 449–458.

    Article  CAS  Google Scholar 

  64. Drath, D., Kahan, B.: Alterations in rat pulmonary macrophage function by the immunosuppressive agents cyclosporine, azathioprine, and prednisolone. Transplantation 35 (1983) 588–592.

    Article  PubMed  CAS  Google Scholar 

  65. Kharazmi, A., Svenson, M., Nielsen, H., Birgens, H.: Effect of cyclosporin A on human neutrophil and monocyte function. Scan. J. Immunol. 21 (1985) 585–591.

    Article  CAS  Google Scholar 

  66. Roilides, E., Robinson, T., Sein, T., Pizzo, P., Walsh, T.:In vitro andex vivo effects of cyclosporin A on phagocytic host defenses againstAspergillus fumigatus. Antimicrob. Agents Chemother. 38 (1994) 2883–2888.

    PubMed  CAS  Google Scholar 

  67. Hörl, W., Wanner, C., Riegel, W., Schlosser, W., Wilms, H., Schollmeyer, P.: Reduction of degranulation of polymorphonuclear leukocytes by immunosuppression in patients following cadaveric renal transplantation. Transplantation 47 (1989) 140–144.

    Article  Google Scholar 

  68. High, K.: The antimicrobial activities of cyclosporine, FK 506, and rapamycin. Transplantation 57 (1994) 1689–1700.

    PubMed  CAS  Google Scholar 

  69. Janco, R., English, D.: Cyclosporine and human neutrophil function. Transplantation 35 (1983) 501–503.

    Article  PubMed  CAS  Google Scholar 

  70. Mueller, E., Kovarik, J., Van Bree, J., Tetzloff, W., Grevel, J., Kutz, K.: Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation. Pharm. Res. 11 (1994) 301–304.

    Article  PubMed  CAS  Google Scholar 

  71. Tolkoff-Rubin, N., Rubin, R.: Uremia and host defenses. N. Engl. J. Med. 322 (1990) 770–772.

    Article  PubMed  CAS  Google Scholar 

  72. Vanholder, R., Ringoir, S.: Infectious morbidity and defects of phagocytic function in end-stage renal disease: a review. J. Am. Soc. Nephrol 3 (1993) 1541–1554.

    PubMed  CAS  Google Scholar 

  73. Corberand, J., Ngyen, F., Laharrague, P., Fontanilles, A., Gleyzes, B., Gyrard, E., Senegas, C.: Polymorphonuclear functions and aging in humans. J. Am. Geriatr. Soc. 29 (1981) 391–397.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Renal Div., Dept. of Internal Medicine, University Hospital, De Pintelaan 185, B-9000, Gent, Belgium

    A. Dhondt M. D., R. Vanholder M. D., Ph. D., M. -A. Waterloos, G. Glorieux, R. De Smet & S. Ringoir M. D., Ph. D.

Authors
  1. A. Dhondt M. D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Vanholder M. D., Ph. D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. -A. Waterloos
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Glorieux
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. De Smet
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. Ringoir M. D., Ph. D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dhondt, A., Vanholder, R., Waterloos, M.A. et al. In vitro effect of cefodizime, imipenem/cilastatin and co-trimoxazole on dexamethasone and cyclosporin A depressed phagocytosis. Infection 26, 120–125 (1998). https://doi.org/10.1007/BF02767775

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02767775

Keywords

Search

Navigation